HR 6094 · 118th Congress 2023โ€“2025, ended

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act

Latest action · Dec 17, 2024 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedOct 26, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act or the PROTECT Rare Act

This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.

Cosponsors 26

Members who signed on, in the order they did. Signatures ran from Oct 26, 2023 to Sep 16, 2024; 3 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-PAMike KellyOriginalOct 26, 2023
D-CAMike ThompsonOriginalOct 26, 2023
R-FLNeal P. DunnOriginalOct 26, 2023
D-MNDean PhillipsNov 1, 2023
D-NMMelanie A. StansburyJan 5, 2024
R-FLGus M. BilirakisJan 12, 2024
D-NJMikie SherrillJan 17, 2024
R-PABrian K. FitzpatrickJan 29, 2024
D-DCEleanor Holmes NortonJan 29, 2024
D-TNSteve CohenFeb 5, 2024
R-NEDon BaconFeb 13, 2024
D-TXLizzie FletcherFeb 14, 2024
D-NCDonald G. DavisFeb 15, 2024
D-MALori TrahanFeb 28, 2024
R-IAMariannette Miller-MeeksFeb 28, 2024
D-MIShri ThanedarFeb 28, 2024
D-ILMike QuigleyFeb 29, 2024
R-TXAugust PflugerMar 5, 2024
D-NJJosh GottheimerMar 5, 2024
D-CASalud O. CarbajalMar 6, 2024
D-MDDavid J. TroneMar 19, 2024
D-NYPaul TonkoMay 14, 2024
D-COJoe NeguseMay 16, 2024
R-NCRichard HudsonMay 16, 2024
D-MAJake AuchinclossSep 6, 2024
D-FLSheila Cherfilus-McCormickSep 16, 2024

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Oct 26, 2023
Health Subcommittee
Referred Nov 3, 2023
HouseWays and Means Committee
Referred Oct 26, 2023
Health Subcommittee
Referred Dec 17, 2024

Actions 4

Everything that happened, newest first.

  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Nov 3, 2023Referred to the Subcommittee on Health.
  3. Oct 26, 2023Introduced in House
  4. Oct 26, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: section 8 of article I of the Constitution The single subject of this legislation is: health care

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 177, October 26, 2023, page H5176.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes.
Short Title(s) as Introduced
Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Oct 26, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.